Maria Bonomi

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial

Carmine Pinto, Paolo Andrea Zucali, Maria Pagano et al. · The Lancet Oncology · 2021 · 103 citations

Medicine, Oncology, Pharmacology +12

A simple model to predict the complicated operative vaginal deliveries using vacuum or forceps

José Antonio Sainz‐Bueno, José Antonio García‐Mejido, Adriana Aquise et al. · American Journal of Obstetrics and Gynecology · 2018 · 63 citations · Full text

Medicine, Gynecology, Obstetrics +10

Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer

Daniel Rayson, Sasha Lupichuk, Kylea Potvin et al. · Breast Cancer Research and Treatment · 2016 · 60 citations

Medicine, Oncology, Pharmacology +17

Glioblastoma-derived Leptin Induces Tube Formation and Growth of Endothelial Cells: Comparison with VEGF Effects

Rita Ferla, Maria Bonomi, László Ötvös et al. · BMC Cancer · 2011 · 55 citations · Full text

Medicine, Endocrinology, Oncology +13

A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207

Paul Wheatley‐Price, Quincy S. Chu, Maria Bonomi et al. · Journal of Thoracic Oncology · 2016 · 36 citations

Medicine, Oncology, Pharmacology +9